Mangoceuticals (MGRX) Change in Account Payables (2024)
Mangoceuticals' (MGRX) quarterly Change in Account Payables came in at -$110160.0 in Q4 2024.
Mangoceuticals (MGRX) Change in Account Payables (2024) Analysis & Trends
Mangoceuticals has disclosed Change in Account Payables across 1 years of filings, most recently posting -$110160.0 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 4.47 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -86.99 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 4.78 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -16.25 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 16.18 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -110,160.00 |
| Dec 31, 2024 | -110,160.00 |